Advertisement
Advertisement
PACB
Pacific Biosciences of California, Inc.
1.35
USDSponsored
-0.05
-3.90%
May 11, 15:33 UTC -4
Closed
After-Market
1.36
+0.01
+0.74%
PACB Earnings Reports
Positive Surprise Ratio
PACB beat 21 of 41 last estimates.
51%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$43.68M
/-$0.12
Implied change from Q1 26 (Revenue/ EPS)
+17.48%
/--
Implied change from Q2 25 (Revenue/ EPS)
+9.84%
/-14.29%
Pacific Biosciences of California, Inc. earnings per share and revenue
On May 07, 2026, PACB reported earnings of -0.12 USD per share (EPS) for Q1 26, beating the estimate of -0.13 USD, resulting in a 12.73% surprise. Revenue reached 37.18 million, compared to an expected 40.79 million, with a -8.84% difference. The market reacted with a -14.55% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 10 analysts forecast an EPS of -0.12 USD, with revenue projected to reach 43.68 million USD, implying an increase of 0.00% EPS, and increase of 17.48% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.45
Actual
-$0.30
Surprise
+34.01%
SI-BONE, Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.10
Surprise
+48.13%
Delcath Systems Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
-$0.03
Surprise
+66.06%
CVRx, Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.51
Actual
-$0.50
Surprise
+2.80%
Treace Medical Concepts, Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.28
Surprise
+10.88%
Sensus Healthcare, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.16
Surprise
-25.49%
LENSAR, Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
$0.18
Actual
$0.00
Surprise
-100.00%
Mettler-Toledo International
Report Date
May 07, 2026 For Q1 26
Estimate
$8.78
Actual
$8.91
Surprise
+1.37%
STERIS plc
Report Date
May 11, 2026 For Q4 26
Estimate
$2.87
Actual
$2.83
Surprise
-1.62%
GLOBUS MEDICAL INC
Report Date
May 07, 2026 For Q1 26
Estimate
$0.93
Actual
$1.12
Surprise
+19.39%
FAQ
What were Pacific Biosciences of California, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Pacific Biosciences of California, Inc. reported EPS of -$0.12, beating estimates by 12.73%, and revenue of $37.18M, -8.84% below expectations.
How did the market react to Pacific Biosciences of California, Inc.'s Q1 2026 earnings?
The stock price moved down -14.55%, changed from $1.65 before the earnings release to $1.41 the day after.
When is Pacific Biosciences of California, Inc. expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Pacific Biosciences of California, Inc.'s next earnings report?
Based on 10
analysts, Pacific Biosciences of California, Inc. is expected to report EPS of -$0.12 and revenue of $43.68M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement